Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001362613 | SCV001558642 | benign | Adams-Oliver syndrome 5 | 2023-06-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001664851 | SCV001872923 | uncertain significance | not provided | 2023-09-26 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Genome- |
RCV001362613 | SCV002553410 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271228 | SCV002553411 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341765 | SCV002639847 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-03-08 | criteria provided, single submitter | clinical testing | The c.4537G>A (p.G1513S) alteration is located in exon 25 (coding exon 25) of the NOTCH1 gene. This alteration results from a G to A substitution at nucleotide position 4537, causing the glycine (G) at amino acid position 1513 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |